Avandia

On May 21, 2007, the Food and Drug Administration (FDA) issued a Safety Alert regarding Avandia. Avandia (Rosiglitazone) is a widely prescribed medication to treat Type-2 Diabetes. Manufactured by GlaxoSmithKline, Avandia was approved for treatment in the United States in 1999. Avandia is also contained in combination with other drugs in medications called Avandryl and Avandamet. More than six million people worldwide have taken the drug to help control blood sugar.

The FDA Safety Alert follows a study appearing in the June 14, 2007 issue of the New England Journal of Medicine. The study was conducted by two doctors at the Cleveland Clinic who evaluated 42 studies. Those studies compared patients taking Avandia with those who were not. The overall study involved 28,000 patients, 15,560 of whom were taking Avandia. The study concludes that patients taking Avandia face a 43% increased risk of heart attack, and a 64% increased risk of dying from heart-related (cardiovascular) disease.

In February 2010, the FDA announced it was currently reviewing reports that Avandia may lead to an increased risk of stroke. A stroke occurs when a blood vessel supplying oxygen to the brain is either blocked, typically by a blood clot, or bursts. As a result, that particular region of the brain does not receive the necessary oxygen to function properly, and brain cells begin to die.

According to recent FDA reports, Avandia may affect several body functions which may increase your risk of stroke, including:

Impacting cholesterol levels
Increasing the heart’s demand for oxygen
Lowering hemoglobin levels
Increasing psychological stress

We Can Help

If you or a loved one has suffered an injury from taking Avandia, Shore Dombrowski Law Firm, PC can help you receive the compensation you deserve. We will fight aggressively to make sure your rights are protected throughout your defective product claim.

Please contact us today to schedule a complimentary initial consultation.